FDA Crackdown Reignites Controversy Over Ethics Of '3-Parent Embryo'

The FDA said the procedure that led to the first "three-parent embryo," violates the regulator's restrictions on genetic engineering. The clampdown could have widespread implications for other advancements in the controversial field of human genetic modification.